IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study	HIV-1-infection	Recruiting	Phase 1	2026-08-17		NCT07596888

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of North Carolina, Chapel Hill	249

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Duke Early Phase Clinical Research Unit	Durham	United States	2
University of North Carolina	Chapel Hill	United States	38

Clinical trials